Client: A leading ophthalmology pharmaceutical company.
Study scope: Support a phase 2B trial with 3,500 participants across 150 global sites, ensuring timely equipment sourcing, setup, and support.
Date: 2021–2024.
Clinichain’s role in this study
1. On-time global delivery:
- Achieved 100% on-time delivery of critical ophthalmic devices (OCTs, slit lamps, fundus cameras) to all 150 trial sites
- Coordinated international logistics, customs clearance, and last-mile delivery.
2. Local sourcing expertise:
- Leveraged regional vendors in LATAM and APAC to minimize lead times and ensure compliance with local regulations.
- Reduced shipping costs and environmental impact through localized procurement.
3. Standardized equipment and setup:
- Pre-deployment calibration and validation ensured consistent performance across all sites.
- All devices met stringent FDA, EMA, ISO, and regional regulatory standards.
4. Comprehensive support and troubleshooting:
- 24/7 multilingual helpdesk provided real-time technical support.
- Vendor SLAs enabled fast repairs and replacements, avoiding disruptions.
- On-site and virtual training ensured site staff were proficient in device usage.
5. Sustainability post-trial:
- Managed eco-friendly disposal and repurposing of equipment at trial conclusion.
Results (2021–2024)
- Timeliness: 100% of sites fully equipped and operational on schedule.
- Regional efficiency: Local sourcing in LATAM and APAC reduced delivery times by 20%.
- Reliability: Ongoing support minimized downtime and ensured consistent data collection.
- Cost optimization: Local partnerships and efficient logistics cut overall costs by 18%.
Clinichain’s expertise in global and regional equipment sourcing ensured a seamless, compliant, and timely trial execution, contributing to the success of this pivotal Phase 2B study.